CorMedix Inc reports results for the quarter ended in March - Earnings Summary

CorMedix

15/05/2023 22:39

* CorMedix Inc  CRMD.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 20 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * CorMedix Inc's reported EPS for the quarter was a loss
of 24
cents​.
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * CorMedix Inc shares had risen by 25.1% this quarter and
gained 22.7% so far this year.
    * The company reported a quarterly loss of $10.57 million.
    * Wall Street's median 12-month price target for CorMedix
Inc is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 09:39 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.20          -0.24          Missed
 Dec. 31 2022      -0.19          -0.20          Missed
 Sep. 30 2022      -0.23          -0.17          Beat
 Jun. 30 2022      -0.21          -0.19          Beat